id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0529-0001,FDA,FDA-2012-D-0529,"Draft Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use--- Labeling for Products That Contain Acetaminophen; Availability",Notice,Notice of Availability,2012-07-05T04:00:00Z,2012,7,2012-07-05T04:00:00Z,2012-09-05T03:59:59Z,2015-10-30T19:07:53Z,2012-16244,0,0,090000648107a968
FDA-2012-D-0529-0002,FDA,FDA-2012-D-0529,"Draft Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use--- Labeling for Products That Contain Acetaminophen",Other,Guidance,2012-07-05T04:00:00Z,2012,7,2012-07-05T04:00:00Z,2012-09-05T03:59:59Z,2012-07-05T13:51:59Z,,0,0,090000648107943e